979 / 1851
Good PS Stage III NSCLC:
What Negative/Null Evidence Do We Have?
Induction chemotherapy:
No advantage when added to concurrent chemo-RT
Consolidation chemotherapy
No advantage when added to concurrent chemo-RT
Concurrent
Chemoradiation
Therapy
Induction
Chemotherapy
Consolidation
Chemotherapy